Browsing byAuthorNsangou, DMM
Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
2012-06-25 | Anti-malaria drug development targeting the M1 alanyl and M17 leucyl aminopeptidases | Thivierge, K; Mathew, RT; Nsangou, DMM; Da Silva, F; Cotton, S; Skinner-Adams, TS; Trenholme, KR; Brown, CL; Stack, CM; Gardiner, DL; Dalton, JP |
2012-06-01 | The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria | Skinner-Adams, TS; Peatey, CL; Anderson, K; Trenholme, KR; Krige, D; Brown, CL; Stack, C; Nsangou, DMM; Mathews, RT; Thivierge, K; Dalton, JP; Gardiner, DL |